Subscribe to Journal
Get full journal access for 1 year
only $41.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Barker JN, Boughan K, Dahi PB, Devlin SM, Maloy MA, Naputo K, et al. Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis. Blood Adv. 2019;3:939–44. https://doi.org/10.1182/bloodadvances.2018028662.
Barker JN, Mazis CM, Devlin SM, Davis E, Maloy MA, Naputo K, et al. Evaluation of cord blood total nucleated and CD34(+) cell content, cell dose, and 8-allele HLA match by patient ancestry. Biol Blood Marrow Transplant. 2020;26:734–44. https://doi.org/10.1016/j.bbmt.2019.11.017.
Barker JN, Kurtzberg J, Ballen K, Boo M, Brunstein C, Cutler C, et al. Optimal practices in unrelated donor cord blood transplantation for hematologic malignancies. Biol Blood Marrow Transplant. 2017;23:882–96. https://doi.org/10.1016/j.bbmt.2017.03.006.
Dehn J, Spellman S, Hurley CK, Shaw BE, Barker JN, Burns LJ, et al. Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR. Blood. 2019;134:924–34. https://doi.org/10.1182/blood.2019001212.
Purtill D, Smith K, Devlin S, Meagher R, Tonon J, Lubin M, et al. Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice. Blood. 2014;124:2905–12.
Konuma T, Kato S, Oiwa-Monna M, Tanoue S, Ogawa M, Isobe M, et al. Cryopreserved CD34(+) cell dose, but not total nucleated cell dose, influences hematopoietic recovery and extensive chronic graft-versus-host disease after single-unit cord blood transplantation in adult patients. Biol Blood Marrow Transplant. 2017;23:1142–50. https://doi.org/10.1016/j.bbmt.2017.03.036.
Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611–8. https://doi.org/10.1182/blood-2002-01-0294.
Barker JN, Kempenich J, Kurtzberg J, Brunstein CG, Delaney C, Milano F, et al. CD34(+) cell content of 126 341 cord blood units in the US inventory: implications for transplantation and banking. Blood Adv. 2019;3:1267–71. https://doi.org/10.1182/bloodadvances.2018029157.
Spellman S, Hurley CK, Brady C, Phillips-Johnson L, Chow R, Laughlin M, et al. Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood. Cytotherapy. 2011;13:848–55. https://doi.org/10.3109/14653249.2011.571249.
Ponce DM, Lubin M, Gonzales AM, Byam C, Wells D, Ferrante R, et al. The use of back-up units to enhance the safety of unrelated donor cord blood transplantation. Biol Blood Marrow Transplant. 2012;18:648–51. https://doi.org/10.1016/j.bbmt.2011.12.588.
Moroff G, Eichler H, Brand A, Kekomaki R, Kurtz J, Letowska M, et al. Multiple-laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood. Transfusion. 2006;46:507–15. https://doi.org/10.1111/j.1537-2995.2006.00758.x.
Flores AI, McKenna DH, Montalban MA, De la Cruz J, Wagner JE, Bornstein R. Consistency of the initial cell acquisition procedure is critical to the standardization of CD34+ cell enumeration by flow cytometry: results of a pairwise analysis of umbilical cord blood units and cryopreserved aliquots. Transfusion. 2009;49:636–47. https://doi.org/10.1111/j.1537-2995.2008.02035.x.
Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213–26. https://doi.org/10.1089/scd.1.1996.5.213.
Akyurekli C, Chan JY, Elmoazzen H, Tay J, Allan DS. Impact of ethnicity on human umbilical cord blood banking: a systematic review. Transfusion. 2014;54:2122–7. https://doi.org/10.1111/trf.12630.
Cairo MS, Wagner EL, Fraser J, Cohen G, van de Ven C, Carter SL, et al. Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report. Transfusion. 2005;45:856–66. https://doi.org/10.1111/j.1537-2995.2005.04429.x.
This research was supported in part by a grant from the National Institute of Health, National Cancer Institute (P30 CA008748).
Conflict of interest
IP has received an educational grant from Merck and serves on a Data and Safety Monitoring Board (DSMB) for ExCellThera. AS has served as the Medical Director at the New York Blood Center/National Cord Blood Program and serves on a DSMB for ExCellThera. JNB has received clinical trial funding from Angiocrine Bioscience and unrestricted educational grants from Gamida Cell and Merck. The authors have no other relevant conflicts of interest to declare.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Politikos, I., Mazis, C.M., Naputo, K.A. et al. Analysis of the CD34+ cell to total nucleated cell content ratio of 619 transplanted and back-up cord blood units. Bone Marrow Transplant (2020). https://doi.org/10.1038/s41409-020-01042-7
Biology of Blood and Marrow Transplantation (2020)